Treatment Options of Macular Edema Secondary to Retinal Vein Occlusion (RVO): A Review

Pokharel, Aradhana and Luan, Jie (2019) Treatment Options of Macular Edema Secondary to Retinal Vein Occlusion (RVO): A Review. Open Journal of Ophthalmology, 09 (02). pp. 70-83. ISSN 2165-7408

[thumbnail of OJOph_2019041216192811.pdf] Text
OJOph_2019041216192811.pdf - Published Version

Download (964kB)

Abstract

Retinal Vein Occlusion (RVO) is a common retinal vascular disease secondary to diabetic retinopathy resulting in permanent loss of vision despite available treatment options. Main vision impending complication of retinal vein occlusion is macular edema. Laser photocoagulation has been an established method for treating macular edema for many years but nowadays intravitreal injection of Anti-Vascular endothelial growth factors (Ranibizumab, Aflibercept Bevacizumab and Pegaptanib sodium) is the treatment of choice for macular edema from retinal vein occlusion. Intra-vitreal corticosteroids Triamcinolone Acetonide and Dexamethasone implant, are also being used to treat in some macular edema cases but with higher rates of side effects. Numerous surgical methods have been attempted for treating RVO and preventing macular edema; they include pars plana vitrectomy, radial optic neurotomy, laser induced chorioretinal anastomosis, and arteriovenous sheathotomy. Surgical methods supposedly relieve compression of the central retinal vein, altering the pathophysiology of vein occlusion at the level of the lamina cribrosa thus improving blood flow and oxygenation. But limitations result from its complications.

Item Type: Article
Subjects: STM Open Press > Medical Science
Depositing User: Unnamed user with email support@stmopenpress.com
Date Deposited: 07 Feb 2023 10:32
Last Modified: 31 Jul 2024 12:56
URI: http://journal.submissionpages.com/id/eprint/276

Actions (login required)

View Item
View Item